
The clinical picture of antithrombin III (AT-III) deficiency is characterized by early manifestations of serious venous thromboembolism. The inheritance is autosomal dominant. The precipitating factors of the clinical signs are infections, trauma and pregnancy. For a correct diagnosis, application of various methods (immunological, amidolytic, electrophoresis) are needed. There are several types of AT-III defect; they are characterized by a decrease in amount and function, a functional decrease, or a pathological heparin-binding. Adequate treatment of thromboembolic episodes caused by AT-III deficiency is a lifelong coumarin therapy. In pregnancy and after surgery heparin can only be given together with AT-III substitution. The decreased AT-III activity may change during treatment and this has a diagnostic importance.
Chromosome Aberrations, Male, Antithrombin III Deficiency, Heparin, Racial Groups, Genetic Variation, Chromosome Disorders, Pregnancy, Thromboembolism, Humans, Female
Chromosome Aberrations, Male, Antithrombin III Deficiency, Heparin, Racial Groups, Genetic Variation, Chromosome Disorders, Pregnancy, Thromboembolism, Humans, Female
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
